BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang C, Fiering SN, Steinmetz NF. Cowpea Mosaic Virus Promotes Anti-Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model. Adv Ther (Weinh) 2019;2:1900003. [PMID: 33969181 DOI: 10.1002/adtp.201900003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Koellhoffer EC, Steinmetz NF. Cowpea Mosaic Virus and Natural Killer Cell Agonism for In Situ Cancer Vaccination. Nano Lett 2022. [PMID: 35713326 DOI: 10.1021/acs.nanolett.2c01328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shahgolzari M, Fiering S. Emerging Potential of Plant Virus Nanoparticles (PVNPs) in Anticancer Immunotherapies. J Cancer Immunol (Wilmington) 2022;4:22-9. [PMID: 35600219 DOI: 10.33696/cancerimmunol.4.061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Beiss V, Mao C, Fiering SN, Steinmetz NF. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy. Mol Pharm 2022. [PMID: 35333531 DOI: 10.1021/acs.molpharmaceut.2c00058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Koellhoffer EC, Mao C, Beiss V, Wang L, Fiering SN, Boone CE, Steinmetz NF. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model. Mol Pharm 2022. [PMID: 34978197 DOI: 10.1021/acs.molpharmaceut.1c00681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Shahrivarkevishahi A, Luzuriaga MA, Herbert FC, Tumac AC, Brohlin OR, Wijesundara YH, Adlooru AV, Benjamin C, Lee H, Parsamian P, Gadhvi J, De Nisco NJ, Gassensmith JJ. PhotothermalPhage: A Virus-Based Photothermal Therapeutic Agent. J Am Chem Soc 2021;143:16428-38. [PMID: 34551259 DOI: 10.1021/jacs.1c05090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gautam A, Beiss V, Wang C, Wang L, Steinmetz NF. Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy. Int J Mol Sci 2021;22:9733. [PMID: 34575893 DOI: 10.3390/ijms22189733] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
7 Chan SK, Steinmetz NF. Isolation of Cowpea Mosaic Virus-Binding Peptides. Biomacromolecules 2021;22:3613-23. [PMID: 34314166 DOI: 10.1021/acs.biomac.1c00712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Boone CE, Wang L, Gautam A, Newton IG, Steinmetz NF. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1739. [PMID: 34296535 DOI: 10.1002/wnan.1739] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
9 Mao C, Beiss V, Fields J, Steinmetz NF, Fiering S. Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors. Biomaterials 2021;275:120914. [PMID: 34126409 DOI: 10.1016/j.biomaterials.2021.120914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chariou PL, Beiss V, Ma Y, Steinmetz NF. In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy. Mater Adv 2021;2:1644-56. [PMID: 34368764 DOI: 10.1039/D0MA00752H] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shahgolzari M, Pazhouhandeh M, Milani M, Fiering S, Khosroushahi AY. Alfalfa mosaic virus nanoparticles-based in situ vaccination induces antitumor immune responses in breast cancer model. Nanomedicine (Lond) 2021;16:97-107. [PMID: 33442986 DOI: 10.2217/nnm-2020-0311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Boone CE, Wang C, Lopez-Ramirez MA, Beiss V, Shukla S, Chariou PL, Kupor D, Rueda R, Wang J, Steinmetz NF. Active Microneedle Administration of Plant Virus Nanoparticles for Cancer in situ Vaccination Improves Immunotherapeutic Efficacy. ACS Appl Nano Mater 2020;3:8037-51. [PMID: 33969278 DOI: 10.1021/acsanm.0c01506] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
13 Wang C, Steinmetz NF. A Combination of Cowpea Mosaic Virus and Immune Checkpoint Therapy Synergistically Improves Therapeutic Efficacy in Three Tumor Models. Adv Funct Mater 2020;30:2002299. [PMID: 34366758 DOI: 10.1002/adfm.202002299] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
14 Chung YH, Cai H, Steinmetz NF. Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications. Adv Drug Deliv Rev 2020;156:214-35. [PMID: 32603813 DOI: 10.1016/j.addr.2020.06.024] [Cited by in Crossref: 94] [Cited by in F6Publishing: 102] [Article Influence: 47.0] [Reference Citation Analysis]
15 Shukla S, Wang C, Beiss V, Steinmetz NF. Antibody Response against Cowpea Mosaic Viral Nanoparticles Improves In Situ Vaccine Efficacy in Ovarian Cancer. ACS Nano 2020;14:2994-3003. [PMID: 32133838 DOI: 10.1021/acsnano.9b07865] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
16 Wu J, Wu H, Nakagawa S, Gao J. Virus-derived materials: bury the hatchet with old foes. Biomater Sci 2020;8:1058-72. [DOI: 10.1039/c9bm01383k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]